Could regenerative drugs unlock a revolutionary new therapy possibility for folks with drug-resistant epilepsy?
Epilepsy is likely one of the most typical neurological issues on the planet. It impacts roughly 50 million folks, and 30% undergo from seizures that can’t be managed with remedy.
19-year-old Anthony Maita is likely one of the thousands and thousands who dwell with drug-resistant epilepsy or DRE – a situation that leaves folks not understanding when or the place the following seizure will happen. DRE could make life difficult at residence, work, college, in relationships, and nearly each facet of an individual’s life.
There could also be new hope on the horizon. Researchers at Mayo Clinic are conducting the first-in-human scientific trial investigating whether or not regenerative drugs has the potential to restore the mind. Maita is Mayo’s first affected person to endure the investigational therapy.
FOR THE PUBLIC: More well being and medical information on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To entry clear and NAT sound variations of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic
Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
